Literature DB >> 32320469

Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.

Takaaki Hato1, Naoki Shimada2, Yoshiyuki Kurata3, Masataka Kuwana4, Kingo Fujimura5, Hirokazu Kashiwagi6, Toshiro Takafuta7, Mitsuru Murata8, Yoshiaki Tomiyama9.   

Abstract

Bleeding manifestations in primary immune thrombocytopenia (ITP) range from skin petechiae to life-threatening intracranial hemorrhage (ICH). However, the relation between these various bleeding manifestations and the platelet count in ITP remains poorly characterized. Using a nationwide database of patients with ITP during the years 2005 to 2014 (10 years) in Japan, we analyzed 19 415 adult patients newly diagnosed with ITP, including 222 with ICH. The frequency of skin purpura was 64.8%, and this increased linearly with thrombocytopenia without a specific platelet count threshold. In contrast, mucosal bleeding (epistaxis and gingival bleeding) and organ bleeding (melena, hematuria, and ICH) increased exponentially with thrombocytopenia at a platelet count threshold of 10 to 15 × 109/L. Age showed a much weaker correlation than platelet count with skin and mucosal bleeding. However, the incidence of organ bleeding increased exponentially above 60 years of age. Multivariate analysis showed that the presence of mucosal bleeding was a risk factor for occurrence of melena and hematuria but not for ICH. The frequency of ICH was 1.1% and risk factors for ICH were age ≥60 years (odds ratio [OR], 3.09; 95% confidence interval [CI], 2.13-4.47; P < .001), platelet count <10 × 109/L (OR, 2.96; 95% CI, 2.11-4.15; P < .001), and the presence of hematuria (OR, 1.56; 95% CI, 1.04-2.35; P = .033). The relation between ICH and platelet count varied with age. This large-scale analysis of risk factors for bleeding in ITP has revealed distinct characteristics of skin, mucosal, and organ bleeding in adult patients with newly diagnosed ITP, thus indicating those who are at a high risk of severe organ bleeding.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32320469      PMCID: PMC7189281          DOI: 10.1182/bloodadvances.2020001446

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  26 in total

1.  Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.

Authors:  George R Buchanan; Leah Adix
Journal:  J Pediatr       Date:  2002-11       Impact factor: 4.406

2.  Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases.

Authors:  Sara Melboucy-Belkhir; Mehdi Khellaf; Alexandre Augier; Marouane Boubaya; Vincent Levy; Guillaume Le Guenno; Louis Terriou; Bertrand Lioger; Mikaël Ebbo; Anne-Sophie Morin; Marie-Paule Chauveheid; Marc Michel; Farid Belkhir; Frédégonde About; Christian Rose; Guillaume Moulis; Arsene Mekinian; Jérôme Stirnemann; Thomas Papo; Stéphane Cheze; Eric Rosenthal; Jean-François Viallard; Nicolas Schleinitz; Lionel Galicier; Daniel Adoue; Olivier Lambotte; Mohamed Hamidou; Bertrand Godeau; Olivier Fain
Journal:  Am J Hematol       Date:  2016-08-22       Impact factor: 10.047

3.  Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.

Authors:  Mette Nørgaard; Annette Ø Jensen; Malene C Engebjerg; Dóra K Farkas; Reimar W Thomsen; Steven Cha; Sean Zhao; Henrik T Sørensen
Journal:  Blood       Date:  2011-01-24       Impact factor: 22.113

4.  Intracranial Hemorrhage in Patients with Hematologic Disorders: Prevalence and Predictive Factors.

Authors:  Weerapat Owattanapanich; Chirayu U Auewarakul
Journal:  J Med Assoc Thai       Date:  2016-01

5.  Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.

Authors:  Bethan Psaila; Aleksandra Petrovic; Lemke K Page; Jill Menell; Matthew Schonholz; James B Bussel
Journal:  Blood       Date:  2009-09-18       Impact factor: 22.113

6.  High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

Authors:  S Cortelazzo; G Finazzi; M Buelli; A Molteni; P Viero; T Barbui
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

Review 7.  Bleeding complications in immune thrombocytopenia.

Authors:  Donald M Arnold
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

8.  Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.

Authors:  Francesco Rodeghiero; Marc Michel; Terry Gernsheimer; Marco Ruggeri; Victor Blanchette; James B Bussel; Douglas B Cines; Nichola Cooper; Bertrand Godeau; Andreas Greinacher; Paul Imbach; Mehdi Khellaf; Robert J Klaassen; Thomas Kühne; Howard Liebman; Maria Gabriella Mazzucconi; Adrian Newland; Ingrid Pabinger; Alberto Tosetto; Roberto Stasi
Journal:  Blood       Date:  2013-01-29       Impact factor: 22.113

9.  The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.

Authors:  Lemke K Page; Bethan Psaila; Drew Provan; J Michael Hamilton; Julian M Jenkins; Andrew S Elish; Martin L Lesser; James B Bussel
Journal:  Br J Haematol       Date:  2007-06-03       Impact factor: 6.998

10.  Presence of Essential Hypertension or Diabetes Mellitus Is a Predictor of Intracranial Bleeding in Elderly Patients: A Study of 108 Patients with Isolated Thrombocytopenia from a Single Reference Center.

Authors:  Rajan Kapoor; Hara Prasad Pati; Manoranjan Mahapatra; Anuradha Monga
Journal:  Turk J Haematol       Date:  2015-06       Impact factor: 1.831

View more
  3 in total

Review 1.  Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline.

Authors:  Wobke E M van Dijk; Robert J J van Es; Maria E P Correa; Roger E G Schutgens; Karin P M van Galen
Journal:  TH Open       Date:  2021-09-09

2.  Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.

Authors:  Shan Chong; Peng Zhao; Rui-Bin Huang; Hu Zhou; Jia-Ning Zhang; Ming Hou; Yi Liu; Hong-Xia Yao; Ting Niu; Jun Peng; Ming Jiang; Yan-Qiu Han; Jian-Da Hu; Ze-Ping Zhou; Lin Qiu; Lian-Sheng Zhang; Xin Wang; Hua-Quan Wang; Ru Feng; Lin-Hua Yang; Liang-Ming Ma; Shun-Qing Wang; Pei-Yan Kong; Wen-Sheng Wang; Hui-Ping Sun; Jing Sun; He-Bing Zhou; Tie-Nan Zhu; Li-Ru Wang; Jing-Yu Zhang; Qiu-Sha Huang; Hai-Xia Fu; Ye-Jun Wu; Yue-Ying Li; Qian-Fei Wang; Qian Jiang; Hao Jiang; Jin Lu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2022-07-26

Review 3.  Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice.

Authors:  Fei Song; Hanny Al-Samkari
Journal:  J Blood Med       Date:  2021-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.